Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System

Stem Cells and Development
Joshua G HunsbergerMahendra Rao

Abstract

There is great need to develop more predictive drug discovery tools to identify new therapies to treat diseases of the central nervous system (CNS). Current nonpluripotent stem cell-based models often utilize non-CNS immortalized cell lines and do not enable the development of personalized models of disease. In this review, we discuss why in vitro models are necessary for translational research and outline the unique advantages of induced pluripotent stem cell (iPSC)-based models over those of current systems. We suggest that iPSC-based models can be patient specific and isogenic lines can be differentiated into many neural cell types for detailed comparisons. iPSC-derived cells can be combined to form small organoids, or large panels of lines can be developed that enable new forms of analysis. iPSC and embryonic stem cell-derived cells can be readily engineered to develop reporters for lineage studies or mechanism of action experiments further extending the utility of iPSC-based systems. We conclude by describing novel technologies that include strategies for the development of diversity panels, novel genomic engineering tools, new three-dimensional organoid systems, and modified high-content screens that may bring toxicology ...Continue Reading

References

Oct 13, 2000·Regulatory Toxicology and Pharmacology : RTP·H OlsonA Heller
Oct 27, 2005·Current Pharmaceutical Design·D SchusterT Langer
Apr 26, 2006·Drug Discovery Today·Frank Sams-Dodd
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·James IngleseChristopher P Austin
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Daniel G Hackam, Donald A Redelmeier
Mar 21, 2007·Nature Chemical Biology·Garry P Nolan
Jun 30, 2007·Nature Reviews. Drug Discovery·Menelas N PangalosOrest Hurko
Jul 31, 2007·Current Opinion in Chemical Biology·Gabriela Gebrin Cezar
Aug 9, 2007·Nature Reviews. Molecular Cell Biology·Francesco PampaloniErnst H K Stelzer
Sep 11, 2007·Drug Discovery Today·Peter SartipyJohan Hyllner
Feb 16, 2008·Science·Francis S CollinsJohn R Bucher
Jun 17, 2008·Lancet·Arrigo SchieppatiAnita Aperia
Oct 3, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Athina MarkouThomas Steckler
Feb 14, 2009·Nature Protocols·Juergen FriedrichLeoni A Kunz-Schughart
Dec 10, 2009·Nature Reviews. Genetics·Michael L Metzker
Dec 30, 2009·Pharmacological Reviews·Marleen WelshM Eileen Dolan
Dec 30, 2009·Nature Methods·Gabsang Lee, Lorenz Studer
Feb 20, 2010·Nature Reviews. Drug Discovery·Steven M PaulAaron L Schacht
Jul 20, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Daniel M RotroffRussell S Thomas
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Stormy J ChamberlainMarc Lalande
Nov 30, 2010·Cell Stem Cell·Saiyong ZhuSheng Ding
Jan 11, 2011·Acta Pharmacologica Sinica·Yi-jia Lou, Xing-guang Liang
Feb 24, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Nina V StieglerMarcel Leist
Mar 9, 2011·Nature Medicine·Lynda ChinP Andrew Futreal
Jun 22, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Liang GuoKyle L Kolaja
Jul 21, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark E HesterBrian K Kaspar
Sep 29, 2011·Nature Reviews. Neurology·Paul H Gordon, Vincent Meininger
Oct 29, 2011·Trends in Cell Biology·Dongeun HuhDonald E Ingber
Nov 9, 2011·Cell Research·Athanasia D PanopoulosJuan Carlos Izpisua Belmonte
Nov 15, 2011·Nature Reviews. Drug Discovery·Marica GrskovicGeorge Q Daley
Dec 21, 2011·Reproductive Toxicology·S PadillaD M Reif
Jan 27, 2012·Nature·Mason A IsraelLawrence S B Goldstein
Mar 2, 2012·Nature Reviews. Drug Discovery·Jack W ScannellBrian Warrington
Jun 7, 2012·Methods in Molecular Biology·Windy A BoydJonathan H Freedman
Jun 19, 2012·Cell Stem Cell·Tokushige NakanoYoshiki Sasai

❮ Previous
Next ❯

Citations

Feb 9, 2016·Neuroscience·S KálmánK Mirnics
Nov 4, 2015·Frontiers in Behavioral Neuroscience·Xun Yu ChoongElizabeth M C Fisher
Aug 13, 2013·Journal of the Chinese Medical Association : JCMA·Chih-Hung ChiangShou-Dong Lee
Jan 22, 2013·Biochemical and Biophysical Research Communications·Wenbo LiuXingguo Liu
Jun 10, 2014·Seminars in Cell & Developmental Biology·Fumiko ItohKohei Miyazono
Jan 8, 2014·Biochemical and Biophysical Research Communications·Li LuWu-Lin Yang
Jun 16, 2017·Glia·Katy L H ColeDavid A Lyons
Jul 3, 2019·Molecular Neurobiology·Mirza Ali Mofazzal JahromiMichael R Hamblin
Oct 18, 2015·BMC Research Notes·Krishna RamaswamyJoseph G Hacia
May 23, 2019·Journal of Neurophysiology·Colin K FranzEvangelos Kiskinis
Feb 4, 2021·International Journal of Molecular Sciences·Lu Qian, Julia Tcw
Jun 24, 2017·Stem Cell Research·Claudia WingM Eileen Dolan

❮ Previous
Next ❯

Methods Mentioned

BETA
dissect
PCR
Light microscopy
chip

Software Mentioned

Tox

Related Concepts

Related Feeds

Brain Organoids in Disease Modeling

Brain organoids are three-dimensional cell culture models derived from human pluripotent stem cells. Since they resemble the embryonic brain, they can be used to help study brain biology, early brain development, and brain diseases. Discover the latest research on brain organoids in disease modeling here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.